- Bortezomib alleviates experimental pulmonary hypertension by regulating intracellular calcium homeostasis in PASMCs
Jun Zhang et al, 2016, American Journal of Physiology-Cell Physiology CrossRef - Severe but reversible pulmonary hypertension in scleromyxedema and multiple myeloma: a case report
Mazen Kreidy et al, 2020, BMC Pulmonary Medicine CrossRef - Baicalein attenuates monocrotaline-induced pulmonary arterial hypertension by inhibiting vascular remodeling in rats
Ruizan Shi et al, 2018, Pulmonary Pharmacology & Therapeutics CrossRef - An integrative review of nonobvious puzzles of cellular and molecular cardiooncology
Paweł Uruski et al, 2023, Cellular & Molecular Biology Letters CrossRef - B-cells in pulmonary arterial hypertension: friend, foe or bystander?
Sébastien Sanges et al, 2024, European Respiratory Journal CrossRef - Histone demethylase JARID1B regulates proliferation and migration of pulmonary arterial smooth muscle cells in mice with chronic hypoxia-induced pulmonary hypertension via nuclear factor-kappa B (NFkB)
Yuanshi Li et al, 2018, Cardiovascular Pathology CrossRef - Co-operative Research on Financing Ecological and Efficiency of Industrial—Evidence from China’s New Energy Industry
Hairong Wang et al, 2022, Mathematical Problems in Engineering CrossRef - Therapeutic effects of baicalin on monocrotaline-induced pulmonary arterial hypertension by inhibiting inflammatory response
Yun Luan et al, 2015, International Immunopharmacology CrossRef - Proteasome Inhibitors Decrease the Viability of Pulmonary Arterial Smooth Muscle Cells by Restoring Mitofusin-2 Expression under Hypoxic Conditions
I-Chen Chen et al, 2022, Biomedicines CrossRef - Baicalin attenuates monocrotaline-induced pulmonary hypertension through bone morphogenetic protein signaling pathway
Zhaohua Zhang et al, 2017, Oncotarget CrossRef